Bumrungrad Hospital PCL
Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology a… Read more
Bumrungrad Hospital PCL (BH) - Net Assets
Latest net assets as of September 2025: ฿29.40 Billion THB
Based on the latest financial reports, Bumrungrad Hospital PCL (BH) has net assets worth ฿29.40 Billion THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿34.04 Billion) and total liabilities (฿4.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿29.40 Billion |
| % of Total Assets | 86.37% |
| Annual Growth Rate | 22.92% |
| 5-Year Change | 47.59% |
| 10-Year Change | 112.21% |
| Growth Volatility | 28.2 |
Bumrungrad Hospital PCL - Net Assets Trend (2000–2024)
This chart illustrates how Bumrungrad Hospital PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bumrungrad Hospital PCL (2000–2024)
The table below shows the annual net assets of Bumrungrad Hospital PCL from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿27.80 Billion | +15.37% |
| 2023-12-31 | ฿24.10 Billion | +20.46% |
| 2022-12-31 | ฿20.01 Billion | +13.55% |
| 2021-12-31 | ฿17.62 Billion | -6.47% |
| 2020-12-31 | ฿18.84 Billion | -7.05% |
| 2019-12-31 | ฿20.27 Billion | +8.11% |
| 2018-12-31 | ฿18.74 Billion | +12.21% |
| 2017-12-31 | ฿16.70 Billion | +12.96% |
| 2016-12-31 | ฿14.79 Billion | +12.88% |
| 2015-12-31 | ฿13.10 Billion | +16.35% |
| 2014-12-31 | ฿11.26 Billion | +17.33% |
| 2013-12-31 | ฿9.60 Billion | +14.42% |
| 2012-12-31 | ฿8.39 Billion | +24.56% |
| 2011-12-31 | ฿6.73 Billion | +10.95% |
| 2010-12-31 | ฿6.07 Billion | +10.91% |
| 2009-12-31 | ฿5.47 Billion | +12.48% |
| 2008-12-31 | ฿4.87 Billion | +11.87% |
| 2007-12-31 | ฿4.35 Billion | +19.86% |
| 2006-12-31 | ฿3.63 Billion | +34.60% |
| 2005-12-31 | ฿2.70 Billion | +30.85% |
| 2004-12-31 | ฿2.06 Billion | +63.57% |
| 2003-12-31 | ฿1.26 Billion | +112.73% |
| 2002-12-31 | ฿592.08 Million | +54.43% |
| 2001-12-31 | ฿383.40 Million | +95.11% |
| 2000-12-31 | ฿196.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bumrungrad Hospital PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2607430252700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿26.07 Billion | 94.86% |
| Common Stock | ฿794.92 Million | 2.89% |
| Other Comprehensive Income | ฿-152.24 Million | -0.55% |
| Other Components | ฿770.70 Million | 2.80% |
| Total Equity | ฿27.49 Billion | 100.00% |
Bumrungrad Hospital PCL Competitors by Market Cap
The table below lists competitors of Bumrungrad Hospital PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CommVault Systems Inc
NASDAQ:CVLT
|
$3.50 Billion |
|
Maxscend Microelectronics Co Ltd
SHE:300782
|
$3.50 Billion |
|
nLIGHT Inc
NASDAQ:LASR
|
$3.50 Billion |
|
Glenmark Pharmaceuticals Limited
NSE:GLENMARK
|
$3.51 Billion |
|
Sangfor Technologies Inc Class A
SHE:300454
|
$3.50 Billion |
|
Bruker Corporation
NASDAQ:BRKR
|
$3.49 Billion |
|
Vietnam Rubber Group Ltd
VN:GVR
|
$3.49 Billion |
|
Hyundai Mipo Dockyard
KO:010620
|
$3.49 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bumrungrad Hospital PCL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,481,128,648 to 27,487,679,879, a change of 4,006,551,231 (17.1%).
- Net income of 7,774,725,876 contributed positively to equity growth.
- Dividend payments of 4,101,253,278 reduced retained earnings.
- Other comprehensive income increased equity by 8,617,803.
- Other factors increased equity by 324,460,830.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿7.77 Billion | +28.28% |
| Dividends Paid | ฿4.10 Billion | -14.92% |
| Other Comprehensive Income | ฿8.62 Million | +0.03% |
| Other Changes | ฿324.46 Million | +1.18% |
| Total Change | ฿- | 17.06% |
Book Value vs Market Value Analysis
This analysis compares Bumrungrad Hospital PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 117.33x to 5.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | ฿1.44 | ฿169.50 | x |
| 2004-12-31 | ฿2.39 | ฿169.50 | x |
| 2005-12-31 | ฿3.01 | ฿169.50 | x |
| 2006-12-31 | ฿4.18 | ฿169.50 | x |
| 2007-12-31 | ฿5.01 | ฿169.50 | x |
| 2008-12-31 | ฿5.61 | ฿169.50 | x |
| 2009-12-31 | ฿6.31 | ฿169.50 | x |
| 2010-12-31 | ฿7.00 | ฿169.50 | x |
| 2011-12-31 | ฿7.76 | ฿169.50 | x |
| 2012-12-31 | ฿9.67 | ฿169.50 | x |
| 2013-12-31 | ฿11.06 | ฿169.50 | x |
| 2014-12-31 | ฿12.55 | ฿169.50 | x |
| 2015-12-31 | ฿14.68 | ฿169.50 | x |
| 2016-12-31 | ฿16.69 | ฿169.50 | x |
| 2017-12-31 | ฿18.91 | ฿169.50 | x |
| 2018-12-31 | ฿21.28 | ฿169.50 | x |
| 2019-12-31 | ฿23.03 | ฿169.50 | x |
| 2020-12-31 | ฿21.36 | ฿169.50 | x |
| 2021-12-31 | ฿19.93 | ฿169.50 | x |
| 2022-12-31 | ฿22.72 | ฿169.50 | x |
| 2023-12-31 | ฿27.07 | ฿169.50 | x |
| 2024-12-31 | ฿31.69 | ฿169.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bumrungrad Hospital PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 28.28%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 30.23%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.19x
- Recent ROE (28.28%) is above the historical average (28.18%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 52.86% | 6.67% | 0.84x | 9.47x | ฿162.73 Million |
| 2003 | 53.78% | 14.43% | 1.04x | 3.60x | ฿542.55 Million |
| 2004 | 45.36% | 16.09% | 1.16x | 2.44x | ฿728.53 Million |
| 2005 | 40.25% | 15.47% | 1.19x | 2.19x | ฿791.22 Million |
| 2006 | 30.20% | 13.88% | 1.19x | 1.83x | ฿732.85 Million |
| 2007 | 36.92% | 17.06% | 1.26x | 1.72x | ฿1.17 Billion |
| 2008 | 24.48% | 13.41% | 1.10x | 1.67x | ฿704.51 Million |
| 2009 | 22.76% | 13.34% | 1.09x | 1.57x | ฿698.39 Million |
| 2010 | 20.73% | 12.50% | 1.10x | 1.51x | ฿651.55 Million |
| 2011 | 23.59% | 14.42% | 0.82x | 2.00x | ฿914.86 Million |
| 2012 | 31.79% | 20.54% | 0.82x | 1.89x | ฿1.83 Billion |
| 2013 | 26.27% | 17.57% | 0.83x | 1.80x | ฿1.56 Billion |
| 2014 | 25.09% | 17.47% | 0.82x | 1.76x | ฿1.64 Billion |
| 2015 | 26.98% | 19.46% | 0.83x | 1.67x | ฿2.16 Billion |
| 2016 | 25.05% | 20.24% | 0.84x | 1.47x | ฿2.18 Billion |
| 2017 | 24.04% | 21.50% | 0.78x | 1.43x | ฿2.30 Billion |
| 2018 | 22.50% | 22.66% | 0.74x | 1.34x | ฿2.31 Billion |
| 2019 | 18.76% | 20.29% | 0.71x | 1.31x | ฿1.75 Billion |
| 2020 | 6.50% | 9.74% | 0.51x | 1.31x | ฿-649.02 Million |
| 2021 | 7.03% | 9.76% | 0.60x | 1.21x | ฿-512.93 Million |
| 2022 | 25.06% | 23.83% | 0.85x | 1.23x | ฿2.97 Billion |
| 2023 | 29.84% | 27.61% | 0.87x | 1.24x | ฿4.66 Billion |
| 2024 | 28.28% | 30.23% | 0.79x | 1.19x | ฿5.03 Billion |
Industry Comparison
This section compares Bumrungrad Hospital PCL's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,757,974,384
- Average return on equity (ROE) among peers: 25.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bumrungrad Hospital PCL (BH) | ฿29.40 Billion | 52.86% | 0.16x | $3.50 Billion |
| Aikchol Hospital Public Company Limited (AHC) | $1.55 Billion | 9.07% | 0.19x | $29.59 Million |
| Bangkok Chain Hospital Public Company Limited (BCH-R) | $6.40 Billion | 17.03% | 0.97x | $429.99 Million |
| Chularat Hospital Public Company Limited (CHG) | $1.12 Billion | 29.84% | 0.38x | $205.50 Million |
| Chiang Mai Ram Medical Business Public Company Limited (CMR) | $5.27 Billion | 8.36% | 0.67x | $21.67 Million |
| Dental Corporation Public Company Limited (D) | $106.33 Million | 39.99% | 1.05x | $9.07 Million |
| Ekachai Medical Care Public Company Limited (EKH) | $953.94 Million | 16.80% | 0.15x | $56.66 Million |
| Genesis Fertility Center Public Company Limited (GFC) | $123.73 Million | 56.28% | 0.53x | $4.77 Million |
| Mukdahan International Hospital Public Company Limited (HANN) | $176.84 Million | 15.70% | 0.95x | $5.00 Million |
| Intermedical Care and Lab Hospital Public Company Limited (IMH) | $123.08 Million | 37.33% | 0.31x | $7.20 Million |